// App-Quantinova.ai

5014 : Association of plasma cell-free DNA concentration [cfDNA] with outcome from taxane therapy (TT) for castration resistant prostate cancer (CRPC).

Researchers

Presenter

  • Niven Mehra

Principal Investigators

  • Rossitza Christova

  • Lorna Pope

  • Suzanne Carreira

  • Jane Goodall

  • David Lorente

  • Nuria Porta

  • Emma Hall

  • Penelope Flohr

  • Gunther Boysen

  • Diletta Bianchini

  • Oliver Sartor

  • Mario A. Eisenberger

  • Karim Fizazi

  • Stephane Oudard

  • Mustapha Chadjaa

  • Sandrine Mace

  • Johann S. De Bono

Medical Centers

  • Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, London, United Kingdom

  • The Institute of Cancer Research, Sutton, United Kingdom

  • Institute for Cancer Research, London, United Kingdom

  • Cancer Biomarkers Laboratory, The Institute of Cancer Research, London, United Kingdom

  • Servicio Oncologia Medica Hospital Universitario La Fe, Valencia, Spain

  • Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom

  • Institute of Cancer Research Clinical Trials and Statistics Unit, Sutton, United Kingdom

  • The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom

  • Tulane University School of Medicine, New Orleans, LA

  • The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD

  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France

  • Department of Medical Oncology, Hopital Europeen Georges Pompidou, Paris, France

  • Sanofi, Paris, France

  • Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, London, United Kingdom

Locations

  • United States

  • Spain

  • France

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Plasma cell-free DNA

Drug/Treatment

  • Cabazitaxel

  • Docetaxel

  • taxane

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • NCT01308580

  • NCT01308567

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved